Anthony DiGiandomenico
@anthonydigiandomenico
Director
Building Cue Biopharma, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Provention Bio, Inc. was founded in 2016 and has no closure on record.
Named alongside
- Aaron G. FletcherDirector
- Amy WangExecutive Officer, Director
- Anish R. SuriExecutive Officer
- Barry SimonDirector
- Cameron GrayChief Executive Officer and President
- Christopher MarlettDirector
- Colin G. SandercockExecutive Officer
- Colin SandercockExecutive Officer
- Christopher MarlettDirector
- James BowieDirector
- James LalondeDirector
- Lon BellDirector
- Michael HeltzenExecutive Officer
- Mohammad HayatExecutive Officer, Director
- Ashleigh PalmerExecutive Officer, Director
- Cameron GrayDirector
- Francisco Leon, M.D.Director
Contribution
Anthony's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Cue Biopharma, Inc.Pharmaceutical Preparations; formerly Imagen Biopharma, Inc.; listed on Nasdaq as CUE; filing with the SEC since 2015Director · Biotechnology · BOSTON, United States
- Provention Bio, Inc.Pharmaceutical Preparations; filing with the SEC since 2017Director · Biotechnology · LEBANON, United States · Founded 2016
- Invizyne Technologies IncBiological Products, (No Diagnostic Substances); formerly Invizyne Technologies Inc; listed on Nasdaq as EXOZ; filing with the SEC since 2024Director · Biotechnology · MONROVIA, United States